Sessa Capital (Master), L.P. 13D and 13G filings for Provention Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-04-28 4:17 pm Sale |
2023-04-27 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 0 0.000% |
-18,403,628![]() (Position Closed) |
Filing |
2023-04-05 08:51 am Purchase |
2023-03-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 18,403,628 17.800% |
337,015![]() (+1.87%) |
Filing |
2023-02-14 3:00 pm Purchase |
2022-12-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 18,066,613 19.990% |
2,456,443![]() (+15.74%) |
Filing |
2022-07-11 5:29 pm Purchase |
2022-07-07 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 15,610,170 19.990% |
9,714,645![]() (+164.78%) |
Filing |
2022-02-14 5:29 pm Purchase |
2021-12-31 | 13G | Provention Bio, Inc. PRVB |
Sessa Capital (Master), L.P. | 5,895,525 9.300% |
5,895,525![]() (New Position) |
Filing |